MDMA | Q69488 |
scholarly article | Q13442814 |
P2093 | author name string | Dafters RI | |
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 877-882 | |
P577 | publication date | 1995-11-01 | |
P1433 | published in | Physiology & Behavior | Q3618986 |
P1476 | title | Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing | |
P478 | volume | 58 |
Q34565712 | 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings |
Q35851128 | A developmental comparison of the neurobehavioral effects of ecstasy (MDMA) |
Q59287161 | Acute Toxicity of 3,4-Methylenedioxymethamphetamine (MDMA) in Sprague–Dawley and Dark Agouti Rats |
Q35745285 | Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function |
Q40353383 | Acute concomitant effects of MDMA binge dosing on extracellular 5-HT, locomotion and body temperature and the long-term effect on novel object discrimination in rats |
Q35095703 | Altered states: the clinical effects of Ecstasy. |
Q34385074 | Behavioral pharmacology of designer cathinones: a review of the preclinical literature |
Q33678859 | Behavioral sensitization and cross-sensitization between methylphenidate amphetamine, and 3,4-methylenedioxymethamphetamine (MDMA) in female SD rats |
Q35539809 | Behavioral sensitization to 3,4-methylenedioxymethamphetamine is long-lasting and modulated by the context of drug administration. |
Q36252777 | Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans. |
Q37337904 | Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans: Lost in translation. |
Q41694692 | Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") and its congeners |
Q43189522 | Cerebral oedema after MDMA ("ecstasy") and unrestricted water intake. Hyponatraemia must be treated with low water input |
Q40168155 | Changes in leptin, ghrelin, growth hormone and neuropeptide-Y after an acute model of MDMA and methamphetamine exposure in rats. |
Q25256989 | Chronic exposure to MDMA (Ecstasy) elicits behavioral sensitization in rats but fails to induce cross-sensitization to other psychostimulants |
Q40554405 | Clozapine reverses hyperthermia and sympathetically mediated cutaneous vasoconstriction induced by 3,4-methylenedioxymethamphetamine (ecstasy) in rabbits and rats. |
Q40594777 | Cutaneous vasoconstriction contributes to hyperthermia induced by 3,4-methylenedioxymethamphetamine (ecstasy) in conscious rabbits. |
Q51980841 | Dancing hot on Ecstasy: physical activity and thermal comfort ratings are associated with the memory and other psychobiological problems reported by recreational MDMA users. |
Q33922322 | Differential behavioural and neurochemical effects of para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine in the rat. |
Q44125648 | Ecstasy and drug consumption patterns: a Canadian rave population study |
Q44418655 | Ecstasy: a review of scientific literature about MDMA |
Q40541816 | Effect of 5-HT depletion by MDMA on hyperthermia and Arc mRNA induction in rat brain |
Q44730978 | Effect of ambient temperature and a prior neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA) on the hyperthermic response of rats to a single or repeated ('binge' ingestion) low dose of MDMA. |
Q52182401 | Effect of once weekly treatment with 3,4-methylenedioxymethamphetamine on schedule-controlled behavior in rats. |
Q45053012 | Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones |
Q37226598 | Effects of MDMA on body temperature in humans |
Q48250458 | Ethanol-MDMA interactions in rats: the importance of interval between repeated treatments in biobehavioral tolerance and sensitization to the combination |
Q47312691 | High ambient temperature facilitates the acquisition of 3,4-methylenedioxymethamphetamine (MDMA) self-administration |
Q46813771 | High ambient temperature increases intravenous methamphetamine self-administration on fixed and progressive ratio schedules in rats |
Q40561021 | Increased anxiety and "depressive" symptoms months after MDMA ("ecstasy") in rats: drug-induced hyperthermia does not predict long-term outcomes. |
Q43832354 | Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ("ecstasy"). |
Q44050776 | Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion |
Q37714504 | Inhibition of the dorsomedial hypothalamus, but not the medullary raphe pallidus, decreases hyperthermia and mortality from MDMA given in a warm environment. |
Q46857178 | Initial deficit and recovery of function after MDMA preexposure in rats |
Q44489483 | Is frequent dosing with ecstasy a risky business for dopamine-containing neurons? |
Q45031827 | Long-term voluntary consumption of MDMA and THC in rats is modified by individual and situational factors |
Q35946697 | MDMA (3,4-Methylenedioxymethamphetamine) or ecstasy: the neuropsychobiological implications of taking it at dances and raves |
Q36410784 | MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress |
Q39345691 | MDMA, Methylone, and MDPV: Drug-Induced Brain Hyperthermia and Its Modulation by Activity State and Environment |
Q73371204 | Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms |
Q24619949 | Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA) |
Q36797987 | Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms |
Q38983638 | Neurotoxicology of Synthetic Cathinone Analogs |
Q48863841 | Pharmacogenetic studies of change in cortisol on ecstasy (MDMA) consumption |
Q44583496 | Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) alters exploratory behavior, reduces monoamine metabolism, and increases forebrain tyrosine hydroxylase fiber density of juvenile rats |
Q35105557 | Preventing Problems in Ecstasy Users: Reduce Use to Reduce Harm |
Q51887349 | Rats preexposed to MDMA display attenuated responses to its aversive effects in the absence of persistent monoamine depletions. |
Q46682053 | Repeated MDMA ("Ecstasy") exposure in adolescent male rats alters temperature regulation, spontaneous motor activity, attention, and serotonin transporter binding |
Q38819567 | Safety pharmacology of acute MDMA administration in healthy subjects. |
Q48405043 | Sex differences in the neurochemical and functional effects of MDMA in Sprague-Dawley rats |
Q48444036 | Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat. |
Q37226593 | State-dependent and environmental modulation of brain hyperthermic effects of psychoactive drugs of abuse |
Q42112531 | Studies on the effect of MDMA ('ecstasy') on the body temperature of rats housed at different ambient room temperatures |
Q45037362 | Studies on the role of dopamine D1 receptors in the development and expression of MDMA-induced behavioral sensitization in rats |
Q48149811 | The distribution of 3,4-methylenedioxymethamphetamine "Ecstasy"-induced c-fos expression in rat brain |
Q46446358 | The effect of long-term repeated exposure to 3,4-methylenedioxymethamphetamine on cardiovascular and thermoregulatory changes. |
Q34830911 | The effects and consequences of selected club drugs |
Q36572459 | The hidden side of drug action: brain temperature changes induced by neuroactive drugs |
Q35146115 | The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA). |
Q40517091 | The role of 5-HT in the impairment of thermoregulation observed in rats administered MDMA ('ecstasy') when housed at high ambient temperature |
Q34112933 | The role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives |
Q46703884 | Thermoregulatory effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans |
Q36666580 | Tolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose binges |
Q22252794 | Toxicity of amphetamines: an update |
Q35306109 | Treadmill running restores MDMA-mediated hyperthermia prevented by inhibition of the dorsomedial hypothalamus. |
Q52289049 | Vasopressin and oxytocin secretion in response to the consumption of ecstasy in a clubbing population. |
Search more.